200 related articles for article (PubMed ID: 15498610)
1. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice.
Carlucci MJ; Scolaro LA; Noseda MD; Cerezo AS; Damonte EB
Antiviral Res; 2004 Nov; 64(2):137-41. PubMed ID: 15498610
[TBL] [Abstract][Full Text] [Related]
2. Emergence of herpes simplex virus-1 syncytial variants with altered virulence for mice after selection with a natural carrageenan.
Mateu CG; Recalde MP; Artuso MC; Hermida G; Linero FN; Scolaro LA; Damonte EB; Pujol CA; Carlucci MJ
Sex Transm Dis; 2011 Jun; 38(6):555-61. PubMed ID: 22256337
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
4. Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection.
Hendrickson BA; Guo J; Brown I; Dennis K; Marcellino D; Hetzel J; Herold BC
Virology; 2000 May; 271(1):155-62. PubMed ID: 10814580
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of a carrageenan from Gigartina skottsbergii against intraperitoneal murine herpes simplex virus infection.
Pujol CA; Scolaro LA; Ciancia M; Matulewicz MC; Cerezo AS; Damonte EB
Planta Med; 2006 Feb; 72(2):121-5. PubMed ID: 16491446
[TBL] [Abstract][Full Text] [Related]
6. Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata.
Talarico LB; Zibetti RG; Faria PC; Scolaro LA; Duarte ME; Noseda MD; Pujol CA; Damonte EB
Int J Biol Macromol; 2004 Apr; 34(1-2):63-71. PubMed ID: 15178011
[TBL] [Abstract][Full Text] [Related]
7. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
Kokuba H; Aurelian L; Neurath AR
Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection.
Petrera E; Coto CE
Phytother Res; 2009 Dec; 23(12):1771-7. PubMed ID: 19441066
[TBL] [Abstract][Full Text] [Related]
10. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
11. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge.
Sajic D; Ashkar AA; Patrick AJ; McCluskie MJ; Davis HL; Levine KL; Holl R; Rosenthal KL
J Med Virol; 2003 Dec; 71(4):561-8. PubMed ID: 14556270
[TBL] [Abstract][Full Text] [Related]
12. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse.
Docherty JJ; Fu MM; Hah JM; Sweet TJ; Faith SA; Booth T
Antiviral Res; 2005 Sep; 67(3):155-62. PubMed ID: 16125258
[TBL] [Abstract][Full Text] [Related]
13. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
Parr MB; Parr EL
Virology; 1999 Jun; 258(2):282-94. PubMed ID: 10366565
[TBL] [Abstract][Full Text] [Related]
14. Critical involvement of CD40 in protection against herpes simplex virus infection in a murine model of genital herpes.
Inagaki-Ohara K; Kawabe T; Hasegawa Y; Hashimoto N; Nishiyama Y
Arch Virol; 2002; 147(1):187-94. PubMed ID: 11855631
[TBL] [Abstract][Full Text] [Related]
15. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity.
Neyts J; De Clercq E
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):8-12. PubMed ID: 7648289
[TBL] [Abstract][Full Text] [Related]
16. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
17. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
Fernández-Romero JA; Abraham CJ; Rodriguez A; Kizima L; Jean-Pierre N; Menon R; Begay O; Seidor S; Ford BE; Gil PI; Peters J; Katz D; Robbiani M; Zydowsky TM
Antimicrob Agents Chemother; 2012 Jan; 56(1):358-68. PubMed ID: 22064530
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
Quenelle DC; Collins DJ; Marciani DJ; Kern ER
Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820
[TBL] [Abstract][Full Text] [Related]
19. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection.
Palliser D; Chowdhury D; Wang QY; Lee SJ; Bronson RT; Knipe DM; Lieberman J
Nature; 2006 Jan; 439(7072):89-94. PubMed ID: 16306938
[TBL] [Abstract][Full Text] [Related]
20. Antiherpetic activity and mode of action of natural carrageenans of diverse structural types.
Carlucci MJ; Ciancia M; Matulewicz MC; Cerezo AS; Damonte EB
Antiviral Res; 1999 Sep; 43(2):93-102. PubMed ID: 10517311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
